CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Palbociclib (ID 28)

Lecture Time
13:30 - 13:50
Speakers
  • Javier Cortes (Madrid, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

Q&A (ID 22)

Lecture Time
10:40 - 10:50
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

Synthetic lethality (ID 17)

Lecture Time
09:00 - 09:20
Speakers
  • Rene Bernards (Amsterdam, NL)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of palbociclib (ID 12)

Lecture Time
16:40 - 17:00
Speakers
  • Angel Guerrero (Valencia, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

CDK2 as the bypass kinase for CDK4/6 inhibition (ID 7)

Lecture Time
14:50 - 15:10
Speakers
  • Nicholas Turner (London, GB)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
Role of CDK 4-6 inhibitors across solid tumors (ID 9) Panel Discussion

Panel Discussion (ID 35)

Lecture Time
15:20 - 16:05
Speakers
  • Alberto Bardelli (Candiolo, IT)
  • Josep Tabernero (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
15:20 - 16:05
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Abemaciclib (ID 30)

Lecture Time
14:10 - 14:30
Speakers
  • Antonio Llombart-Cussac (Valencia, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
The disappointing results of initial CDKI and their role in other disease (ID 7) Educational session

Dinaciclib (ID 24)

Lecture Time
11:10 - 11:35
Speakers
  • Cristina Saura (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
Interaction between CDKs, CDKI and other targets (ID 6) Educational session

PIK3 (ID 19)

Lecture Time
09:40 - 10:00
Speakers
  • Violeta Serra (Barcelona, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5) Educational session

Preclinical evidence of activity of abemaciclib (ID 14)

Lecture Time
17:20 - 17:40
Speakers
  • Maria Lallena (Alcobendas, ES)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
The concept of CDK inhibition according to the targeted CDK subtype (ID 4) Educational session

CDK 4-6 inhibition (ID 9)

Lecture Time
14:30 - 14:50
Speakers
  • Monica Arnedos (Villejuif, FR)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The role of CDK along the mitotic process in normal and pathological condition (ID 3) Educational session

Integration of multiple signalling pathways through control of CDK activation (ID 2)

Lecture Time
13:20 - 13:40
Speakers
  • Luca Malorni (Prato, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
13:20 - 14:30